Chondrosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
Conditions:   Metastatic Primary Central Chondrosarcoma;   Unresectable Primary Central Chondrosarcoma Interventions:   Drug: Belinostat;   Drug: Guadecitabine Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2020 Category: Research Source Type: clinical trials

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Condition:   Mesenchymal Chondrosarcoma Intervention:   Drug: Trabectedin Sponsors:   Italian Sarcoma Group;   PharmaMar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2020 Category: Research Source Type: clinical trials